Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in PatientsWith Type 2 Diabetes - Hartman, M L; Sanyal, A J; Loomba, R (Diabetes Care, 2020)